Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Dora Games(Athena Group (United States)), Jun Zhao(Athena Group (United States)), Elizabeth Penniman(Exemplar Genetics (United States)), Terry Guido(Athena Group (United States)), S. Hagopian(Boston Children's Hospital), Martin Montoya‐Zavala(Boston Children's Hospital), Catherine Blackwell(University of Massachusetts Amherst), Paul J. Leibowitz(Exemplar Genetics (United States)), Patricia Borthelette(Exemplar Genetics (United States)), Ben Wolozin(National Institute of Mental Health), Mike Lee(Hoshi University), Karen Khan, Peter Seubert(Sunesis (United States)), Ferdie Soriano(Athena Group (United States)), Hua Tan(Sunesis (United States)), Lennart Mucke(Gladstone Institutes), James Vitale(Millennium Engineering and Integration (United States)), Lisa McConlogue(Gladstone Institutes), Robin Barbour(Sunesis (United States)), Sam Wadsworth(Exemplar Genetics (United States)), Eliezer Masliah(University of California San Diego), Ivan Lieberburg(Sunesis (United States)), Ree Alessandrini(Exemplar Genetics (United States)), Lisa Paganini(Athena Group (United States)), Kelly Johnson‐Wood, Tony Carr(Athena Group (United States)), Ben Snyder(Exemplar Genetics (United States)), David S. Adams(Worcester Polytechnic Institute), Thomas Donaldson(Exemplar Genetics (United States)), James A. Clemens(Eli Lilly (United States)), Sheila P. Little(Eli Lilly (United States)), Mike Power(Athena Group (United States)), Dale Schenk(Athena Group (United States)), Frances P. Gillespie(Exemplar Genetics (United States))
Nature
February 1, 1995
Cited by 2,508


Related Papers